0001225208-11-027048.txt : 20111229
0001225208-11-027048.hdr.sgml : 20111229
20111229122608
ACCESSION NUMBER: 0001225208-11-027048
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20100306
FILED AS OF DATE: 20111229
DATE AS OF CHANGE: 20111229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDREOTTI LAMBERTO
CENTRAL INDEX KEY: 0001208099
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 111285740
MAIL ADDRESS:
STREET 1: BRISTOL MYERS SQUIBB CO
STREET 2: RT 206 & PROVIINCELLE ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4/A
1
doc4a.xml
X0304
4/A
2010-03-06
2010-03-09
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001208099
ANDREOTTI LAMBERTO
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
1
Pres, COO & CEO Designate
Restricted Stock Units
0.0000
2010-03-06
4
M
0
6600.0000
0.0000
D
2010-03-06
Common Stock, $0.10 par value
6600.0000
13200.0000
D
Each restricted stock unit converts into one share of common stock upon vesting.
One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock.
This Form 4 is being amended to reflect the correct number of derivative securities beneficially owned following this reported transaction. The number of derivative securities beneficially owned following the transaction reported for this award in a Form 4 filed on March 8, 2011 was also reported incorrectly.
Exhibit 24 - Power of Attorney
/s/ Robert J. Wollin, attorney-in-fact for Lamberto Andreotti
2011-12-29
EX-24
2
andreotti_poa.txt
Exhibit 24
POWER OF ATTORNEY
I, Lamberto Andreotti, Director of Bristol-Myers Squibb Company
(the "Company"), a corporation duly organized and existing under the laws
of the State of Delaware, in the United States of America, and having its
principal place of business at 345 Park Avenue, New York, New York, do
hereby constitute and appoint each of Sandra Leung, Katherine R. Kelly,
and Robert J. Wollin, individually, as my lawful attorney-in-fact and in
my name, place and stead to execute and deliver any and all documents
relating to insider reporting requirements under Section 16 of the
Securities Exchange Act of 1934, with respect to securities issued by the
Company, including, without limitation, the execution and filing of all
Forms 3, 4 and 5, and to take such other action, as such attorney considers
necessary or appropriate, to effectuate such transactions. This Power of
Attorney shall remain in full force and effect until I am no longer required
to file Forms 3, 4, and 5 with respect to securities issued by the Company,
unless earlier revoked.
IN WITNESS WHEREOF, I have executed this Power of Attorney on this
20th day of September, 2011.
/s/ Lamberto Andreotti
Lamberto Andreotti